Study to Evaluate HM15275 in Obese or Overweight Subjects Without Diabetes Mellitus
Public ClinicalTrials.gov record NCT07205900. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate Efficacy, Safety, and Tolerability of HM15275 for 36 Weeks in Obese or Overweight Subjects Without Diabetes Mellitus
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This Study is a Phase 2 Study to Evaluate Efficacy, Safety, and Tolerability of HM15275 for 36 Weeks in Obese or Overweight Subjects Without Diabetes Mellitus.
Study identification
- NCT ID
- NCT07205900
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 267 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 2, 2025 (Actual)
- Primary completion
- Jan 2027 (Estimated)
- Completion
- Jan 2027 (Estimated)
- Last update posted
- Apr 8, 2026
2025 – 2027
United States locations
- U.S. sites
- 14
- U.S. states
- 7
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| ProSciento Inc | Chula Vista | California | 91911 | — |
| Accellacare of Duly - Duly Oak Lawn | Oak Lawn | Illinois | 60453 | — |
| Accellacare of McFarland | Ames | Iowa | 50010 | — |
| Accellacare of Cary - Cary Medical Group | Cary | North Carolina | 27511 | — |
| Accellacare of Hickory | Hickory | North Carolina | 28601 | — |
| Raleigh Medical Group, P.A. | Raleigh | North Carolina | 27609 | — |
| Accellacare of Piedmont - Piedmont HealthCare | Statesville | North Carolina | 28626 | — |
| Accellacare of Wilmington, LLC | Wilmington | North Carolina | 28401 | — |
| Accellacare of Winston Salem | Winston-Salem | North Carolina | 27103 | — |
| Accellacare of Charleston | Mt. Pleasant | South Carolina | 29464 | — |
| Accellacare of Bristol-PAC of Tennessee | Bristol | Tennessee | 37620 | — |
| Bristol-Internal Medicine and Pediatric Associates of Bristol, P.C. | Bristol | Tennessee | 37620 | — |
| Texas Clinical Research Institute | Arlington | Texas | 76012 | — |
| Velocity Clinical Research, Dallas | Dallas | Texas | 75230 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07205900, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 8, 2026 · Synced Oct 28, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT07205900 live on ClinicalTrials.gov.